Morgan Stanley's Fee-Based Growth Makes Shares Attractive

Michael M. Santiago Morgan Stanley (NYSE:MS) has been a poor performer over the past year, missing out on the strong stock market rally and instead declining by 12%. That said, since recommending shares in October, MS has returned about 19%, validating my buy rating. In January, shares did reach my $93 price target, but investor reaction to its most recent earnings report has been mixed, causing a pullback. With a new CEO at the helm, it is timely to revisit whether shares are still a “buy.” I remain bu ...